59676-960 : Doxil 2 mg/ml Intravenous Injection, Suspension, Liposomal


NDC: 59676-960
Labeler: Janssen Products, Lp
Product Type: Human Prescription Drug
Drug Name:  Doxil
Dosage Form: Intravenous Injection, Suspension, Liposomal
Application #: NDA050718
Rev. Date: 


NDC Package Codes:

  • 59676-960-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (59676‑960‑01) > 10 ML IN 1 VIAL, SINGLE‑USE
  • 59676-960-02: 1 VIAL, SINGLE‑USE IN 1 CARTON (59676‑960‑02) > 25 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Doxorubicin Hydrochloride

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Anthracycline Topoisomerase Inhibitor [EPC]
  • Anthracyclines [Chemical/Ingredient]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0338-0063 Doxil 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
  • 0338-0067 Doxil 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59676-960 QR Code

< Prev: 59676-800Next: 59676-966 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.